Astera Labs, Inc. (ALAB) - What Are Researchers Thinking About This Stock?

Key Points

• Analyst sentiment is moderately bullish: Astera Labs has a consensus “Moderate Buy” rating, split between 11 buy and 11 hold recommendations, with an average 12-month price target of $340.79.
• Recent results exceeded expectations: Quarterly EPS was $0.80 versus the $0.69 consensus, while revenue rose 104.5% year over year to $392.4 million, ahead of estimates.
• Insiders have been selling amid elevated valuation: Insiders sold 408,558 shares worth $127.3 million over the past three months, while the stock carries a market capitalization of $45.02 billion and a price-to-earnings ratio of 128.47.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-two ratings firms that are presently covering the stock, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $340.79.

A number of research analysts have weighed in on the stock. Royal Bank Of Canada raised their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Barclays boosted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. Roth Capital restated a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Jefferies Financial Group upped their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of the business's stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the completion of the sale, the director directly owned 3,309 shares of the company's stock, valued at approximately $909,842.64. The trade was a 73.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company's stock, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Total Clarity Wealth Management Inc. boosted its holdings in Astera Labs by 103.4% during the 3rd quarter. Total Clarity Wealth Management Inc. now owns 2,215 shares of the company's stock worth $788,000 after acquiring an additional 1,126 shares during the last quarter. Oppenheimer & Co. Inc. grew its stake in shares of Astera Labs by 12.5% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 4,322 shares of the company's stock worth $1,539,000 after acquiring an additional 481 shares in the last quarter. Park Avenue Securities LLC raised its holdings in shares of Astera Labs by 7.8% in the third quarter. Park Avenue Securities LLC now owns 58,995 shares of the company's stock valued at $21,000,000 after purchasing an additional 4,281 shares during the last quarter. Verdence Capital Advisors LLC purchased a new stake in shares of Astera Labs in the third quarter valued at about $372,000. Finally, Flagship Harbor Advisors LLC raised its holdings in shares of Astera Labs by 8.4% in the third quarter. Flagship Harbor Advisors LLC now owns 3,606 shares of the company's stock valued at $1,284,000 after purchasing an additional 278 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Stock Up 0.9%

Shares of NASDAQ:ALAB opened at $259.51 on Tuesday. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The stock's 50 day moving average is $310.76 and its 200-day moving average is $252.11. The firm has a market capitalization of $45.02 billion, a price-to-earnings ratio of 128.47 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. During the same period last year, the business earned $0.44 EPS. Astera Labs's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts anticipate that Astera Labs will post 2.71 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.